ARCHIVES

Senate committee approves $1.1 billion increase for NIH.

This article is from The Cancer Letter archive.

Vol. 30 No. 37 | October 1, 2004

Download PDF Visit The Full Archive

Related Articles

IND-Exempt Trials May Need Special Review, HCFA Says.

September 29, 2000

New NCAB Appointees Include Some Old Hands; Korn Renamed Chairman

May 13, 1988

FDA Proposes To Drop Specific Requirements For Reprint Distribution On Off-Label Uses.

February 22, 2008

Solomon Garb’s Questions/Answers

January 9, 1981

FDA Approves Ribavirin Phase 102 Trials

October 30, 1987

In Brief: New Environmental Cancer Research Center Opened In Texas; Califano: No Promises

July 7, 1978